Keap1-Nrf2-ARE通路在阿尔茨海默病发病机制中的潜在作用

doi:10.3969/j.issn.1006-6233.2022.10.032

摘要
图/表
参考文献
相关文章 (15)

[1] Wang W Z,Zhao F P,et al.Mitochondria dysfunction in the pathogenesis of Alzheimer's disease:recent advances[J].Molecular Neurodegeneration,2020,15(1):30.
[2] Kandimalla R,Reddy PH.Multiple faces of dynamin-related protein 1 and its role in Alzheimer's disease pathogenesis[J].Biochim Biophys Acta,2016,1862(4):814-828.
[3] Uttara B,Singh AV,Zamboni P,et al.Oxidative stress and neurodegenerative diseases:a review of upstream and downstream antioxidant therapeutic options[J].Current Neuropharmacology,2009,7(1):65-74.
[4] Bradley-Whitman MA,Timmons MD,et al.Nucleic acid oxidation:an early feature of Alzheimer's disease[J].Journal of Neurochemistry,2014,128(2):294-304.
[5] Nam LB,Keum YS.Binding partners of NRF2:functions and regulatory mechanisms[J].Archives of Biochemistry and Biophysics,2019,15(678):108184.
[6] Yamamoto M,Kensler TW,et al.The Keap1-Nrf2-ARE system:a thiol-based sensor-effector apparatus for maintaining redox homeostasis[J].Physiological Reviews,2018,98(3):1169-1203.
[7] David JA,Rifkin WJ,et al.The Nrf2/Keap1/ARE pathway and oxidative stress as a therapeutic tar-get in type II diabetes mellitus[M].Diabetes Res,2017.4826724.
[8] Joshi G,Gan K,et al.Increased Alzheimer's diseaselike pathology in the APP/PS1DeltaE9 mouse model lacking Nrf2 through modulation of autophagy[J].Neurobiol Aging,2015,36(2):664-679.
[9] Kerr,et al.Partridge Direct Keap1-Nrf2-ARE disruption as a potential therapeutic target for Alzheimer's disease[J].PLOS Genetics,2017,13(3):1006593.
[10] Yu,et al.Protective roles of isoastilbin against Alzheimer's disease via Nrf2mediated antioxidation and antiapoptosis[J].Int Mol Med,2019,43(3):1406-1416.
[11] Bahn,et al.NRF2/ARE pathway negatively regulates BACE1 expression and ameliorates cognitive deficits in mouse Alzheimer's models[J].Proc Natl Acad Sci U S A,2019,116(25):12516-12523.
[12] Jo,et al.Nrf2 reduces levels of phosphorylated tau protein by inducing autophagy adaptor protein NDP52[J].Nature Communications,2014,25(5):3496.
[13] Tang,et al.Nrf2 mediates the expression of BAG3 and autophagy cargo adaptor proteins and tau clearance in an age dependent manner[J].Neurobiol Aging.2018,63(5):128-139.
[14] Cuadrado,et al.Pharmacological targeting of GSK-3 and NRF2 provides neuroprotection in a preclinical model of tauopathy[J].Redox Biol,2018,14(4):522-534.
[15] Zhu,et al.Allicin improves endoplasmic reticulum stress-related cognitive deficits via PERK/Nrf2 antioxidative signaling pathway[J].Eur Pharmacol,2015,762(9):239-246.
[16] Terada,et al.In vivo direct relation of tau pathology with neuroinflammation in early Alzheimer's disease[J].Neurol,2019,266(9):2186-2196.
[17] Tom,et al.Gedunin inhibits oligomeric abeta1-42-induced microglia activation via modulation of Nrf2-NF-kappaB signaling[J].Mol Neurobiol,2019,56(11):7851-7862.
[18] Yu,et al.Protective roles of isoastilbin against Alzheimer's disease via Nrf2mediated antioxidation and antiapoptosis[J].Int Mol Med,2019,43(3):1406-1416.
[19] Zhang,et al.Induction of acetylcholinesterase expression during apoptosis in various cell types[J].Cell Death and Differentiation,2002,9(8):790-800.
[20] Kitaoka,et al.Effects of Nrf2 deficiency on mitochondrial oxidative stress in aged skeletal muscle[J].Physiol Rep,2019,7(3):13998.
[21] Peng,et al.Activation of Nrf2 by costunolide provides neuroprotective effect in PC12 cells[J].Food Funct,2019,10(7):4143-4152.
[22] Tapias,et al.Benfotiamine treatment activates the Nrf2/ARE pathway and is neuroprotective in a transgenic mouse model of tauopathy[J].Hum Mol Genet,2018,27(16):2874-2892.